Genome-Scale Study ID's Hundreds of Drug Targets for Huntington's
Thursday, November 29, 2012 - 17:30
in Biology & Nature
Scientists seeking to develop treatments for Huntington's disease just got a roadmap that could dramatically speed their discovery process. Researchers at the Buck Institute have used RNAi technology to identify hundreds of "druggable" molecular targets linked to the toxicity associated with HD. The gene RRAS, involved in cell motility and neuronal development , was among the diverse range of modifiers identified. RRAS was revealed as a potent modulator of HD toxicity in multiple HD models.